Recursion Pharmaceuticals (RXRX) Tmuɣli n wazal
Ṛṛbem n lḥedd$3.76Yettwalemmaḍ 25 Sep 2026 21:56 UTC
Beddel-3.09%
Asnulfu n AI: RXRX
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Recursion Pharmaceuticals, Inc. operates as a biotechnology company. The company combines artificial intelligence with automation to conduct experimental biology in parallel for testing compounds against cellular disease models. Recursion Pharmaceuticals serves clients worldwide.
